Serbian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
hepatitis b/главобоља
Веза се чува у привремену меморију
Страна 1 од 96 резултати
Long-term safety and tolerability of entecavir in patients with chronic hepatitis B in the rollover study ETV-901.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
OBJECTIVE
To review long-term safety data from the rollover study ETV-901, focusing on adverse events (AEs) with a potential nucleos(t)ide association.
METHODS
The open-label study ETV-901 (AI463901) assessed the safety of entecavir in chronic hepatitis B patients who received entecavir, lamivudine
Safety and immunogenicity of concomitant versus nonconcomitant administration of hepatitis B, tetanus-diphtheria, and measles-mumps-rubella vaccines in healthy eleven- to twelve-year-olds.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
OBJECTIVE
To study safety and immunogenicity of concomitant administration of hepatitis B (HB), Tetanus-diphtheria (Td), and Measles-mumps-rubella (MMR) vaccines in healthy 11-12-year-olds.
METHODS
One hundred ninety-seven healthy 11-12-year-olds from the general community were randomized in an
Immunologic effects on peripheral lymphoid cells from patients with chronic hepatitis type B during administration of recombinant interleukin 2.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Nine patients with chronic hepatitis type B were treated with recombinant interleukin 2 (rIL-2). Side effects were limited to low-grade fever and headache, which were transient and tolerable for the patients. Seven normal volunteers and nine patients with chronic active hepatitis were administered
Schistosomiasis japonicum diagnosed on liver biopsy in a patient with hepatitis B co-infection: a case report.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
BACKGROUND
Chronic hepatitis B virus and schistosomiasis are independently associated with significant mortality and morbidity worldwide. Despite much geographic overlap between these conditions and no reason why co-infection should not exist, we present what is, to the best of our knowledge, the
Clinical evaluation of a yeast recombinant hepatitis B vaccine in healthy hospital staff in Singapore.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
A yeast recombinant hepatitis B vaccine (subtype adw), derived from purification of HBsAg particles, expressed in the yeast Saccharomyces cerevisiae which contained the gene for HBsAg, was evaluated in 31 healthy adult hospital staff members in Singapore. Each subject received a 10 mcg dose of
Human plasma derived hepatitis B vaccine: Kenyan experience.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
OBJECTIVE
To determine the efficacy and safety of hepaccine B.
METHODS
Vaccination on first-come-first-served basis.
METHODS
Kenya Medical Research Institute (KEMRI) staff and families at Nairobi, Kenya.
METHODS
A total of 107 vaccinees aged 0-10 years and 10 years and above.
RESULTS
Antibody to
Comparison of a triple antigen and a single antigen recombinant vaccine for adult hepatitis B vaccination.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Hepatitis B and its sequelae are a major public health problem. Vaccines have been available for almost 20 years; however the disease still remains a global problem. Many factors contribute to the failure to control hepatitis B, including the limited nature of the vaccination programs implemented
Telbivudine for the management of chronic hepatitis B virus infection.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
BACKGROUND
Telbivudine (LdT) is an L-nucleoside that is structurally related to lamivudine. It is highly selective for hepatitis B virus (HBV) and inhibits viral DNA synthesis. LdT was approved by the US Food and Drug Administration on October 25, 2006, for the treatment of chronic HBV infection in
[A Case of Severe Peripheral Polyneuropathy Occurring after Entecavir Treatment in a Hepatitis B Patient].
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Entecavir (Baraclude®) is an oral antiviral drug used for the treatment of HBV. Entecavir is a reverse transcriptase inhibitor which prevents the HBV from multiplying. Most common adverse reactions caused by entecavir are headache, fatigue, dizziness, and nausea. Until now, there has been no report
Peg-interferon plus nucleotide analogue treatment versus no treatment in patients with chronic hepatitis B with a low viral load: a randomised controlled, open-label trial.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Antiviral treatment is currently not recommended for patients with chronic hepatitis B with a low viral load. However, they might benefit from acquiring a functional cure (hepatitis B surface antigen [HBsAg] loss with or without formation of antibodies against hepatitis B surface antigen
Antiviral therapy with nucleotide/nucleoside analogues in chronic hepatitis B: A meta-analysis of prospective randomized trials.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Nucleotide/nucleoside analogues (antiviral therapy) are used in the therapy of HBeAg positive and HBeAg negative chronic hepatitis B. We analyzed ten selected randomized controlled with 2557 patients to estimate the effect of antiviral drugs in chronic hepatitis B with compared to placebo.
Liver transplantation for hepatitis B cirrhosis: clinical sequela of passive immunization.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Aggressive administration of hepatitis B immune globulin (HBIg) has been shown to prevent hepatitis B viral (HBV) infection of the allograft; however, the clinical sequela of such therapy has not been previously described. We reviewed our experience with high dose, intravenous infusion of an
Phase I clinical trial in healthy adults of a nasal vaccine candidate containing recombinant hepatitis B surface and core antigens.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
BACKGROUND
The nasal vaccine candidate (NASVAC), comprising hepatitis B virus (HBV) surface (HBsAg) and core antigens (HBcAg), has been shown to be highly immunogenic in animal models.
METHODS
A phase I double-blinded, placebo-controlled randomized clinical trial was carried out in 19 healthy male
Hepatotoxicity and hematologic complications induced by fusidic acid in a patient with hepatitis B cirrhosis: A case report.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
OBJECTIVE
To assess the clinical effectiveness and cost-effectiveness of adefovirdipivoxil (ADV) and pegylated interferon alfa-2a (PEG) for the treatment of adults with chronic hepatitis B infection (CHB).
METHODS
Electronic databases for the period from 1995-6 to April 2005. Websites of the
Најкомплетнија база лековитог биља подржана науком
- Ради на 55 језика
- Биљни лекови потпомогнути науком
- Препознавање биљака по слици
- Интерактивна ГПС мапа - означите биље на локацији (ускоро)
- Читајте научне публикације повезане са вашом претрагом
- Претражите лековито биље по њиховим ефектима
- Организујте своја интересовања и будите у току са истраживањем вести, клиничким испитивањима и патентима
Упишите симптом или болест и прочитајте о биљкама које би могле да помогну, укуцајте неку биљку и погледајте болести и симптоме против којих се користи.
* Све информације се заснивају на објављеним научним истраживањима
